REFERENCES
- Singh V K, Biswas S, Anand R, Agarwal S S. Experimental autoimmune uveitis as animal model for human posterior uveitis. Indian J Med Res. 1998; 107: 53–67, [PUBMED], [INFOTRIEVE], [CSA]
- Forrester J V, Liversidge J, Dua H S, Towler H, McMenamin P G. Comparison of clinical and experimental uveitis. Curr Eye Res. 1990; 9(Suppl)75–84, [PUBMED], [INFOTRIEVE], [CSA]
- Caspi R R. Immunogenetic aspects of clinical and experimental uveitis. Reg Immunol. 1992; 4(5)321–330, [PUBMED], [INFOTRIEVE], [CSA]
- Tibbles P M, Edelsberg J S. Hyperbaric oxygen therapy. N Engl J Med. 1996; 334: 1642–1648, [PUBMED], [INFOTRIEVE], [CSA]
- Hyperbaric Oxygen Therapy Committee Report., E M Camporesi. Undersea and Hyperbaric Medical Society, Kensington, MD 1996
- Lightman S, Kok H. Developments in the treatment of uveitis. Expert Opin Invest Drugs. 2002; 11(1)59–67, [CSA]
- Rosenberg W M, Moss P A, Bell J I. Molecular aspects of autoimmunity: a review. Curr Eye Res. 1992; 11(Suppl)17–23, [PUBMED], [INFOTRIEVE], [CSA]
- Careless D J, Inman R D. Acute anterior uveitis: clinical and experimental aspects. Semin Arthritis Rheum. 1995; 24(6)432–441, [PUBMED], [INFOTRIEVE], [CSA]
- Smith J R, Hart P H, Williams K A. Basic pathogenic mechanisms operating in experimental models of acute anterior uveitis. Immunol Cell Biol. 1998; 76(6)497–512, [PUBMED], [INFOTRIEVE], [CSA]
- Howes E L, jr, Cole P W, Adair T M, Cruse V K, Pollycove M. Cellular and vascular responses in acute experimental ocular inflammation. Invest Ophthalmol Vis Sci. 1994; 35(12)4031–4038, [PUBMED], [INFOTRIEVE], [CSA]
- Helbig H, Kittredge K L, Gurley R C, Thurau S R, Palestine A G, Nussenblatt R B. Endotoxin–induced production of inflammatory mediators by cultured ciliary epithelial cells. Curr Eye Res. 1990; 9(5)501–505, [PUBMED], [INFOTRIEVE], [CSA]
- Csukas S, Paterson C A, Brown K, Bahatterjee P. Time course of rabbit ocular inflammatory response and mediator release after intravitreal endotoxin. Invest Ophthalmol Vis Sci. 1990; 31: 382–387, [PUBMED], [INFOTRIEVE], [CSA]
- Okamoto N, Nishimura Y, Goami K, Harino S. Effect of hyperbaric oxygen on ophthalmic artery blood velocity in patients with diabetic neuropathy. Jpn J Ophthalmol. 1998; 42(5)406–410, [PUBMED], [INFOTRIEVE], [CSA]
- Kuroki A M, Kitaoka T, Tanuguchi H, Amemiya T. Hyperbaric oxygen therapy reduces visual field defect after macular hole surgery. Ophthalmic Surg Lasers. 2002; 33: 200–206, [CSA]
- Speit G, Dennog C, Eichhorn U, Rothfuss A, Kaina B. Induction of heme oxygenase-1 and adaptive protection against the induction of DNA damage after hyperbaric oxygen treatment. Carcinogenesis. 2000; 21(10)1795–1799, [PUBMED], [INFOTRIEVE], [CSA]
- Yıldırım G, Bastug M, Akcil I E, Ficicilar H, Koc E, Zaloglu N. Does the platelet activating factor affect the antioxidant defense system? The possible role of hyperbaric oxygenation. Biol Trace Elem Res. 2000; 78(1–3)7–12, [CSA]
- Dennog C, Radermacher P, Barnett Y A, Speit G. Antioxidant status in humans after exposure to hyperbaric oxygen. Mutat Res. 1999; 428(1–2)83–89, [PUBMED], [INFOTRIEVE], [CSA]